David Tutera Makes DIY Easy With New Michaels Partnership
Entertaining expert David Tutera has a brand new line for DIY lovers that allows them to make their own flowers for any special occasion, including birthdays and weddings. Tutera sits down with Alyssa Julya Smith in Los Angeles to talk about creating the line and what he hopes people get from the project.
Tutera also talks about his shoe line that is exclusively for special occasions, saying the shoes are perfect for brides on their big day since they are shoes "that should be seen." The entertaining expert, who has planned numerous celebrity weddings, gave his take on the Royal Wedding next year, including what he thinks Meghan Markel will wear on the big day.
As a style expert, Tutera is well versed in all things fashion and he says he knew ultra violet with the Pantone color of the year in 2018 before it was even announced. Tutera's DIY Sizzix line is exclusively available at Michaels.
Kim Kardashian’s shapewear brand Skims has doubled its valuation to $3.2 billion. Investors have taken a bet on the success of this brand in the form of fresh funds for the two-year-old company.
McDonald's missed on both the top and bottom lines in its Q4 earnings, marking the fourth loss for the fast-food giant in the past eight quarters. It comes as higher costs from food to wages ate into the blue-chip company's profits. George Seay, CEO of investment advisor Annandale Capital, joined Wake Up with Cheddar to discuss the recent numbers and the better-than-expected success of the McPlant burger made with plant-based Beyond Meat. "They're changing with the times, and they have to," Seay noted. "You can just sell a Big Mac to everybody. There's a lot of people who don't want to eat a Big Mac anymore."
Moderna launched a clinical trial of a COVID-19 booster shot specifically targeting the omicron variant. The first participant has already received a dose, and Moderna expects to enroll about 600 adults total, split between two groups. In the first group, participants will have previously received two doses of the Moderna vaccine, and in the second, participants will have received its booster. Dr. Paul Burton, chief medical officer at Moderna, joined Cheddar’s Opening Bell to discuss the trial, yearly boosters, and what lies ahead for the company.
